Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 2 (2020) Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation Abstract  similar documents
Yu. P. Skirdenko, N. A. Nikolaev
"... anticoagulants (DOACs) (χ2=1.44; p<0.49, Pearson) and significantly more in individuals taking warfarin ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... and systemic thromboembolic (STE) complications as warfarin, although DOACs were associated with less risk ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... of direct oral anticoagulants (DOACs) compared with vitamin K antagonists due to the extensive body ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... anticoagulants (DOACs) inhibitors, as antidotes for DOAC when stopping life-threatening bleeding. DOAC therapy ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..."
 
Vol 16, No 3 (2020) Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue Abstract  similar documents
O. D. Ostroumova, I. V. Goloborodova
"... to the progression of osteoporosis and its complications, which in turn can negatively affect the prognosis ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... complications is analyzed according to the evidence base medicine approach. Possible hemorrhagic complications ..."
 
Vol 16, No 2 (2020) The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment Abstract  similar documents
К. V. Lobastov, I. V. Schastlivtsev
"... complications of DOACs. The results of published trials are reflected in the current guidelines ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... Data on the problem of thromboembolic complications in non-valvular atrial fibrillation ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... В данной статье затрагиваются вопросы  применения прямых оральных антикоагулянтов (ПОАК) у ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... patients, including warfarin (39.5%), direct oral anticoagulants (DOAC) (46.5%) and low-molecular weight ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... of clinical studies on the possibility of effective reduction in frequency of thromboembolic complications ..."
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
"... is specified. Modifications of the patient dental health card are offered to prevent complications associated ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... stroke. The risk of thromboembolic complications increases significantly when performing for electrical ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
"... препаратами (ацетилсалициловая кислота, варфарин) отдельно представлены альтернативные антитромботические ..."
 
Vol 7, No 2 (2011) PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? Abstract  similar documents
I. V. Zotova, D. A. Zateyshchikov
"... complications. Possible ways to minimize the hemorrhagic risk in different groups of hypertensive patients who ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..."
 
Vol 15, No 5 (2019) Anticoagulant Therapy as a Tool for the Prevention of Cognitive Impairment Associated with Atrial Fibrillation Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, S. P. Korchagina, T. M. Ostroumova, M. S. Chernyaeva, A. A. Kirichenko
"... to direct oral anticoagulants (DOACs). In randomized clinical trials, meta-analyses and systematic reviews ..."
 
Vol 15, No 5 (2019) Clinical Case: Atypical Warfarin-induced Skin Necrosis Abstract  similar documents
T. V. Kondratieva, L. V. Popova, S. S. Karachev, A. S. Lishuta, M. Z. Kanevskaya
"... Warfarin-induced skin necrosis (WISN) is a rare complication of antivitamin K therapy, which occurs ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... to a decrease in the number of thromboembolic complications, and from the results of some RCTs – to a decrease ..."
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... терапии антагонистом витамина К варфарином и прямым ингибитором тромбина дабигатраном. ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... complications (CHA2DS2-VASc≥2) was revealed in 93% patients (n=245), 65% (n=172) of them received warfarin ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... was the low adherence to medical support, which directly related with the frequency of complications ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... be considered in patients with low adherence for prevention of thromboembolic complications. ..."
 
Vol 7, No 6 (2011) DABIGATRAN ETEXILATE FOR PREVENTION OF CARDIOEMBOLIC COMPLICATIONS IN NONVALVULAR ATRIAL FIBRILLATION: HOW TO DO THE INTERVENTION MORE EFFECTIVE AND SAFER Abstract  similar documents
I. S. Yavelov
"... Application of dabigatran etexilate for prevention of cardioembolic complications in nonvalvular ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... варфарин. В связи с известными недостатками применения варфарина, для клинической практики очень важным ..."
 
Vol 14, No 1 (2018) THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
"... values, at which the risk of cardioembolic stroke and other thromboembolic complications is proven ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"... fibrillation (AF) with the risk level of thromboembolic complications (TEC), calculated with the СHADS2 and CHA ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... complications was found in 1% (n=3) of patients in 2012 and 0.6% (n=3) in 2016. All these patients received ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... Представлен анализ современной литературы по проблеме применения варфарина у больных ..."
 
Vol 16, No 2 (2020) Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function Abstract  similar documents
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko
"... comprehensively. Along with the prevention of thromboembolic complications, it is necessary that the selected ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... Цель. Провести анализ структуры затрат , ассоциированных с подбором дозы варфарина и контролем ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... the development of bleeding during anticoagulant therapy with direct oral anticoagulants (DOAC). Material ..."
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... межлекарственным взаимодействием. К числу наиболее популярных антикоагулянтов относят варфарин, который наряду со ..."
 
Vol 8, No 2 (2012) QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL Abstract  similar documents
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts
"... варфарин, после выхода из международного клинического исследования. Материал и методы. В исследовании ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... предсердий. Рассмотрены факторы эффективности терапии варфарином, а также возможности применения новых ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... благоприятный профиль эффективности и безопасности ривароксабана в сравнении с варфарином у пациентов 75 лет и ..."
 
Vol 16, No 5 (2020) Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis) Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, N. V. Furman, V. V. Agapov
"... to 2011-2012 mainly due to the increase in the spectrum of direct OACs (DOACs) (p<0.05). Conclusion ..."
 
Vol 7, No 4 (2011) SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS Abstract  similar documents
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts
"... варфарина у больных фибрилляцией предсердий. Материал и методы. У 68 пациентов с сочетанием фибрилляции ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... ) к проведению плановой кардиоверсии (КВ) при лечении варфарином и дабигатраном Материал и методы ..."
 
Vol 10, No 4 (2014) NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
 
Vol 14, No 5 (2018) Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report) Abstract  similar documents
G. S. Krasnov, I. V. Kazancev
"... -Drug Interaction Checker) выявлены взаимодействия, которые привели к НЛР: варфарин+розувастатин ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... каждого пациента просчитаны баллы по шкале CHA2DS2-VASc. Для пациентов, получавших варфарин, оценивали ..."
 
Vol 16, No 3 (2020) Thrombosis of Prosthetic Cardiac Valve: Difficulties of Diagnostics on the Example of a Clinical Case with Lethal Outcome Abstract  similar documents
A. A. Novoselova, S. S. Yakushin
"... установкой механического протеза в аортальную позицию и дальнейшего постоянного приема варфарина, с ..."
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... causes of death in patients with DM are macrovascular complications. Intensive hypoglycemic therapy ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... modification of cardiovascular complications in the perioperative period. Particular attention has recently ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... предсердий (ФП) относятся антитромботическая терапия антагонистами витамина К (варфарин), антитромбоцитарными ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... ацетилсалициловая кислота, варфарин, тиклопидин и клопидогрель. Приводятся данные по изучению новых ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... исследования ARISTOTLE, в котором сравниваются эффективность и безопасность апиксабана в сравнении с варфарином ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
"... варфарина и выбора новых оральных антикоагулянтов на основе результатов фармакогенетического тестирования, а ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... предсердий (ФП) относятся антитромботическая терапия антагонистами витамина К (варфарин), антитромбоцитарными ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... фармакоэкономическую эффективность применения дабигатрана этексилата в сравнении с варфарином в профилактике сердечно ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... to the weighted average auctions prices for NOACs. The costs of monitoring and treatment of complications were ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... результате комбинированной антикоагулянтной терапии фраксипарином и варфарином у больной дилатационной ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... %) was revealed in 79%. 8.45% of the vitamin K antagonist treated patients developed hemorrhagic complications. 16 ..."
 
Vol 11, No 2 (2015) THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS Abstract  similar documents
E. EL. Trisvetova
"... Despite progress in reducing the risk of hypertension (HT) complications, control of blood ..."
 
Vol 1, No 3 (2005) TRANSIENT ISCHEMIC ATTACK AS AN ARTERIAL HYPERTENSION COMPLICATION Abstract  similar documents
G. N. Gorochovskaya, A. P. Kondrachin, A. I. Martinov
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... % мужчин), в т.ч. варфарин – 817 пациентам (26%) и новые оральные антикоагулянты (НОАК) – 518 (16 ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... результатам основных исследований не уступали или превосходили варфарин в отношении баланса эффективности и ..."
 
Vol 7, No 6 (2011) CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM Abstract  similar documents
Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov
"... The thrombus formation in the left ventricle (LV) cavity is a frequent complication of myocardial ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... year worldwide, and cardiovascular complications happen in 500 000 - 900 000 patients. Aim ..."
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... of risk modification of cardiovascular complications in the perioperative period. Therefore, special ..."
 
Vol 2, No 3 (2006) APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY Abstract  similar documents
S. V. Nedogoda
"... perioperative complications during aortocoronary bypass procedure and operations on heart valves are analyzed ..."
 
Vol 16, No 5 (2020) Actual Issues of the Cardiac Complications Risk Assessment and Correction in Non-Cardiac Surgery Abstract  similar documents
A. N. Sumin
"... is constantly increasing; cardiac complications are the leading cause of death in such surgeries. So ..."
 
Vol 16, No 2 (2020) The Risk of Myocardial Infarction in Patients with Atrial Fibrillation Taking a Direct Thrombin Inhibitor: Myths and Reality Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova, D. A. Napalkov
"... for the efficacy of dabigatran in preventing myocardial infarction and other vascular complications in patients ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... complications of the treatment are discussed. ..."
 
Vol 5, No 6 (2009) ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS Abstract  similar documents
N. A. Dmitrieva, S. N. Tolpygina
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... and hemorrhagic complications in patients with atrial fibrillation (AF) during planned surgical interventions ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... of thromboembolic complications. In connection with the categorical refusal of the patient from warfarin ..."
 
Vol 13, No 1 (2017) ENDOVASCULAR TREATMENT OF CAROTID ATHEROSCLEROSIS: CONCERNS AND PERSPECTIVES Abstract  similar documents
T. V. Tvorogova, E. S. Bulgakova, F. B. Shukurov, B. A. Rudenko, O. M. Drapkina, A. S. Shanoyan
"... , is also wide-spread but it is associated with more periprocedural complications. Knowledge of risk factors ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... tools used to assess risks of thromboembolic and hemorrhagic complications and general approaches ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
 
Vol 9, No 4 (2013) VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
 
Vol 11, No 6 (2015) Neoatherosclerosis in the stent Abstract  similar documents
A. A. Komkov, V. P. Mazaev, S. V. Ryazanova
"... of complications such as early stent thrombosis and restenosis of stent were solved in a considerable degree ..."
 
Vol 5, No 4 (2009) PREVENTION OF LEFT VENTRICLE SYSTOLIC DYSFUNCTION IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AFTER CARDIAC REVASCULARIZATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi, M. L. Kenzhaev, S. R. Kenzhaev
"... effects on LV systolic function and prevents post-reperfusion complications.  ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"...   on  clinical  state  and  cardiovascular  complications  (CVC)  in  patients with  chronic  heart  failure ..."
 
Vol 12, No 6 (2016) THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION Abstract  similar documents
T. E. Imaev, A. E. Komlev, R. S. Akchurin
"... replacement by CoreValve system were included into the study. Complications including perioperative mortality ..."
 
Vol 10, No 3 (2014) THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE Abstract  similar documents
K. V. Davtyan, O. N. Tkacheva, A. A. Kalemberg, S. N. Koretsky
 
Vol 3, No 1 (2007) DIHYDROPYRIDINE CALCIUM ANTAGONISTS: DATA OF EVIDENCE BASED MEDICINE AND RECOM-MENDATIONS ON PRACTICAL USE Abstract  similar documents
S. Y. Martsevich
"... on the risk of cardiovascular complications. The place of dihydropyridine calcium antagonists in modern ..."
 
Vol 16, No 5 (2020) Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years Abstract  similar documents
S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina
 
Vol 16, No 4 (2020) Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues Abstract  similar documents
M. V. Zhuravleva, A. B. Prokofiev, E. V. Shikh, S. Yu. Serebrova, G. I. Gorodetskaya, E. Yu. Demchenkova
 
Vol 16, No 6 (2020) An Elderly Comorbid Patient with Atrial Fibrillation: What is Important to Know and What Should be Considered When Prescribing Anticoagulants? Abstract  similar documents
T. V. Pavlova
"... complications. As a consequence, the choice of specific anticoagulant should be based on a solid evidences ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... с традиционными препаратами (ацетилсалициловая кислота, варфарин) с точки зрения эффективности и ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... % of patients were informed of possible AF complications, of which less than a third – about the risk of stroke ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... .9%) – pernanent. Results. While assessing the risk of thromboembolic complications on the CHA2DS2-VASc scale ..."
 
Vol 15, No 6 (2019) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation Abstract  similar documents
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... Цель. Изучить безопасность применения прямых оральных антикоагулянтов (ПОАК) у пациентов с ..."
 
Vol 13, No 6 (2017) ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE Abstract  similar documents
E. A. Kolomiets, I. A. Kurmukov, Sh. R. Kashiya, N. S. Besova, S. V. Limareva, A. P. Sandomirskaya
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
 
Vol 6, No 6 (2010) REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" Abstract  similar documents
A. A. Aleksandrov
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... the impact of the assessment by angiographic SYNTAX Score scale on in-hospital complications and lethality ..."
 
Vol 4, No 1 (2008) MICROALBUMINURIA AS A FORECAST FACTOR FOR CARDIO-VASCULAR COMPLICATIONS AND A MARKER OF THERAPY EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. A. Haisheva, L. I. Katelnitskaya
 
1 - 100 of 291 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)